Annual report pursuant to Section 13 and 15(d)

RELATED PARTY TRANSACTIONS

v3.8.0.1
RELATED PARTY TRANSACTIONS
12 Months Ended
Dec. 31, 2017
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 17: RELATED PARTY TRANSACTIONS  

 

Shu-Chih Chen, Ph.D., a member of the Board of Directors and spouse of Steven C. Quay, Ph.D., M.D., the Company’s CEO, has provided consultancy services to the Company.  Those services primarily include providing scientific and technical expertise in Atossa’s negotiations and ongoing arrangements with the manufacturer of endoxifen which is located in Taiwan.  The cost of the services provided by Dr. Chen were approximately $27,000 through December 31, 2016 and have been approved by the Company’s audit committee.

 

Ensisheim Partners LLC, which is under sole ownership and control by Drs. Quay and Chen, purchased the following shares of common stock directly from the Company in at-the-market transactions which were approved by the Company’s audit committee:

 

Purchase Date   Number of Shares     Price per Share  
January 19, 2016     3,333     $ 3.30  
February 16, 2016     1,000     $ 7.95  
March 9, 2016     1,000     $ 5.55  

 

There were no related party transactions during the year ended December 31, 2017.